chr1-108827292-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152763.5(AKNAD1):c.1849G>T(p.Val617Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,458,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152763.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AKNAD1 | NM_152763.5 | c.1849G>T | p.Val617Leu | missense_variant | 11/16 | ENST00000370001.8 | |
LOC105378891 | XR_947687.3 | n.122+3574C>A | intron_variant, non_coding_transcript_variant | ||||
AKNAD1 | NR_049760.2 | n.2061G>T | non_coding_transcript_exon_variant | 10/14 | |||
LOC105378891 | XR_007066273.1 | n.147+3574C>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AKNAD1 | ENST00000370001.8 | c.1849G>T | p.Val617Leu | missense_variant | 11/16 | 1 | NM_152763.5 | P2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250656Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135506
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1458012Hom.: 0 Cov.: 32 AF XY: 0.00000276 AC XY: 2AN XY: 725446
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.1849G>T (p.V617L) alteration is located in exon 11 (coding exon 10) of the AKNAD1 gene. This alteration results from a G to T substitution at nucleotide position 1849, causing the valine (V) at amino acid position 617 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at